[Influencing the lack of concentration in hyperkinetic school children with Aponeuron].
The authors, after typologically defining three etiopathogenetically different forms of lack of concentration power, report the therapeutic effects produced by Aponeuron administered to 38 eight- to thirteen-year-old hyperkinetic children lacking adequate concentration power but being of normal intelligence. The results reported in this paper are based upon comparative psychometric tests, valuation scales used by parents and teachers, and the grades received before and after a three- to six-month treatment. They provide statistical evidence of an increase in concentration power and a decrease in both fatigability and motor unrest. Obviously, objections frequently made to the treatment of encephalopathic children with centrally stimulating drugs are not justified providing indication is furnished expertly.
D000097:Acetonitriles / Q000627:therapeutic use*; D000293:Adolescent; D000607:Aminoacetonitrile / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000662:Amphetamines / Q000627:therapeutic use*; D001288:Attention; D002648:Child; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy*
D000097:Acetonitriles; D000662:Amphetamines; D000607:Aminoacetonitrile
Zur Beeinflussung der Konzentrationsschwäche bei hyperkinetischen Schulkindern mit Aponeuron